fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Ipca Laboratories Ltd

Ipca Laboratories Ltd

Updated on July 10, 2019

Stock/Share Code - IPCALAB

Ipca Laboratories is a integrated pharmaceutical company manufacturing and marketing over 350 formulations and 80 APIs covering various therapeutic segments.

Below is the details of IPCALAB Ipca Laboratories Ltd

Market Cap₹11,854 Cr.
Current Price ₹956.95 as on 15 Jul 19
52 Week High / Low Price₹1,046 / ₹590.1
Face Value₹2
Stock P/E26.06
Book Value₹248.25
Dividend Yield0.11 %
ROCE9.33 %
ROE8.83 %
Sales Growth (3yrs)1.13 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has reduced debt. Company is virtually debt free.
Cons: Stock is trading at 3.78 times its book value The company has delivered a poor growth of 2.82% over past five years. Tax rate seems low Company has a low return on equity of 6.96% for last 3 years. Dividend payout has been low at 4.04% of profits over last 3 years

Ipca Laboratories Ltd Price Chart

Ipca Laboratories Ltd Price Chart

Ipca Laboratories Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹148.55 26.06 ₹98,336.74 Cr. 0.49 ₹635.88 Cr. -52.63 2.68 7163.92 10.41
2. Cipla ₹550.55 29.66 ₹45,028.9 Cr. 0.54 ₹357.68 Cr. 57.90 19.09 4403.98 9.64
3. Dr Reddy's Labs ₹2,627.6 22.81 ₹44,478.27 Cr. 0.75 ₹455.4 Cr. 67.36 13.39 4029.60 7.75
4. Piramal Enterp. ₹2,078 25.32 ₹44,159.07 Cr. 1.02 ₹456.86 Cr. -88.42 23.02 3679.67 8.85
5. Aurobindo Pharma ₹575.6 16.21 ₹39,396.97 Cr. 0.37 ₹585.38 Cr. 15.67 30.70 5292.20 22.85
6. Biocon ₹252.7 43.80 ₹32,514 Cr. 0.18 ₹213.7 Cr. 63.88 30.72 1528.80 8.41
7. Torrent Pharma. ₹18.9 36.27 ₹26,480.39 Cr. 0.89 -₹152 Cr. -37.72 8.67 1856.00 13.23
8. Ipca Labs. ₹344 26.06 ₹11,853.72 Cr. 0.11 ₹109.47 Cr. 113.35 6.69 833.81 9.33

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ipca Laboratories Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019
Sales855884750669713865860782854998948834
YOY Sales Growth %13.04%18.42%9.38%6.49%-16.53%-2.23%14.58%16.84%19.7%15.4%10.24%6.69%
Expenses735749644598691715698673740825716659
Material Cost %36.65%36.14%32.35%34.66%37.51%34.12%34.19%32.75%32.52%31.4%31.63%32.26%
Employee Cost %20.96%19.9%21.47%23.73%24.48%21.65%21.21%21.57%22.88%20.42%18.6%21.21%
Operating Profit1201351067122149162109114173232175
OPM %14%15%14%11%3%17%19%14%13%17%24%21%
Other Income5664611111314141315
Interest665666665256
Depreciation424343434344444344434342
Profit before tax77926426-211101237278141197141
Tax %38%40%35%-73%5%12%14%28%16%15%19%23%
Net Profit48554144-20961065166120160109
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018TTM
Sales9191,0461,2671,5481,8812,3292,7783,2353,0882,8043,1023,1933,633
Sales Growth %23.06%13.77%21.16%22.19%21.49%23.83%19.28%16.43%-4.54%-9.2%10.65%2.94%%
Expenses7438861,1021,2391,4581,8652,2182,4992,5562,5282,6682,7482,940
Material Cost %44.67%46.13%41.21%43.25%40.8%38.95%39.27%34.85%37.02%37.33%35.7%34.84%%
Manufacturing Cost %7.38%7.44%7.23%6.3%6.63%7.35%10.45%7.94%9.53%9.83%9.24%9.4%%
Employee Cost %11.18%13.39%14.11%13.39%13.91%13.83%13.55%14.77%17.53%21.52%21.76%22.32%%
Other Cost %20.27%20.07%26.44%19.24%16.19%19.93%16.55%19.68%18.71%21.47%19.29%19.51%%
Operating Profit176160166309423464561736531276435445693
OPM %19%15%13%20%22%20%20%23%17%10%14%14%19%
Other Income24732441-21219213328214055
Interest24243632314234282931262718
Depreciation25323946556584101177161171174172
Profit before tax151177114272334369461629358111258283557
Tax %19%20%20%23%23%24%28%24%28%17%27%18%
Net Profit1221419120925528033147725693188233455
EPS in Rs9.5410.986.9316.2419.7921.7425.6037.8320.297.3314.9218.47
Dividend Payout %15%14%30%17%16%14%15%13%5%0%7%5%

Compounded Sales Growth

  • 10 Years:: 11.81%
  • 5 Years:: 2.82%
  • 3 Years:: 1.13%
  • TTM:: 12.86%

Compounded Profit Growth

  • 10 Years:: 4.86%
  • 5 Years:: -6.99%
  • 3 Years:: -3.24%
  • TTM:: 95.15%

Return on Equity

  • 10 Years:: 15.03%
  • 5 Years:: 11.07%
  • 3 Years:: 6.96%
  • Last Year:: 8.83%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Share Capital25252525252525252525252525
Equity Capital2525.0924.9925.0425.1425.1725.2425.2425.2425.2425.2425.2425.27
Reserves4615836148501,0291,2371,5451,9562,2082,2582,4502,6703,111
Borrowings239353450454530601617595929865716628330
Other Liabilities263216282297334472528648671812835861991
Trade Payables65.4266.6965.4669.31184.17258.05218.82295.32344.01444.5371.39385.73464.09
Total Liabilities9881,1771,3701,6261,9182,3352,7153,2243,8333,9604,0264,1834,458
Fixed Assets3744135636366989131,0751,3061,7531,9771,9461,8551,770
Gross Block509.23577.09763.99878.47985.581284.511524.851851.292465.92137.322276.992358.72
Accumulated Depreciation132.19164.38200.96242287.76371.69449.52545.18712.94160.74331.02504.11
CWIP5712817389595129165267129957336
Investments25325749494322298297212216322
Other Assets5316047349021,0771,2851,4881,7241,7321,7571,7732,0402,329
Inventories232.21259.52299.83370.84462.51663.98733.34838.3916.98831.93873.54873.171055.55
Trade receivables180.98263.76342.77391.91369.87345.11415.93448.76353.55441.45501.98594.38632.06
Cash Equivalents5.577.595.848.298.449.2554.6669.22113.19161.9817.53131.03259.81
Loans n Advances112.6173.3385.23130.52196.1182.91186.62232.93218.91220.06262.93314.67122.32
Total Assets9881,1771,3701,6261,9182,3352,7153,2243,8333,9604,0264,1834,458

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Cash from Operating Activity113110155194215222387515455696271324
Profit from operations187.82186.44268.57337.49380.76519.08578.6763.45539.76312.72420.02463.45
Working Capital Changes-50.68-46.05-90.06-97.55-102.16-216.85-100.02-118.48-9.96412.34-94.56-82.18
Taxes paid-24.73-30.08-23.59-46.42-64.03-79.9-91.73-130.19-74.46-29.06-54.32-57.41
Cash from Investing Activity-91-145-106-127-199-228-261-362-686-214-146-119
Fixed Assets Purchased-89.11-143.7-78.75-143.44-194.62-239.38-228.55-371.14-554.87-241.76-134.53-72.32
Fixed Assets Sold1.230.890.631.011.260.951.180.811.561.671.02
Investments purchased-504.28-574.97-481.68-481.95-618.27-1315.61-1805.99-1903.12-2037.90-2100-2456.04
Investments sold499.19570.48455.32491.1610.411315.611832.391906.22046.14.192107.372472.86
Cash from Financing Activity-2137-51-64-176-81-138255-414-156-130
Proceeds from Shares01.772.312.562.190.760.3100000
Proceeds from Borrowings32.0788.8215.0271.2195.63137.23110.3966.9487.75151.8367.794.15
Repayment of Borrowings-12.97-14.79-48.16-69.05-41.54-81.47-96.92-110.85-109.63-517.2-196.01-181.79
Interest Paid-21.13-16.86-29.37-28.78-29.22-36.7-34.3-28.29-31.28-28.45-22.84-22.48
Dividends Paid-18.54-21.94-33.62-37.87-43.86-46.66-46.78-66.12-36.85-15.34-0.24-15.33
Net Cash Flow22-22-1145142568-3174

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
ROCE %27%24%16%25%26%24%24%27%13%4%9%9%
Debtor Days729299927254555142575968
Inventory Turnover4.424.254.534.624.514.143.984.123.523.213.643.66

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Ipca Laboratories Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.